Open AccessInfliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report
Author(s) -
Binbin Huang,
Lichun Han,
Geng-Feng Liu,
Xiaodan Lv,
Guang-li Gu,
Shiquan Li,
Lan Cui,
Huiqin Wang,
Lijun Zhan,
Xiaoping Lv
Publication year - 2020
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v26.i46.7425
Subject(s) - infliximab , medicine , ulcerative colitis , dermatomyositis , dermatology , gastroenterology , inflammatory bowel disease , tumor necrosis factor alpha , disease
Joint, skin, oral cavity, and eye lesions are the most common extraintestinal manifestations of ulcerative colitis that can occur before or after its onset. The cases of ulcerative colitis with dermatomyositis (DM) are rare. In this study, we report a rare case of ulcerative colitis with DM that was effectively treated with infliximab.